China Extends Probe Into EU Pork Imports
The Chinese commerce ministry decided to extend its antidumping investigation into EU pork products by six months to Dec. 16, citing the 'complexity' of the case, according to an official notice.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
a minute ago
- CNBC
New entrance fee to visit Europe set to triple, says European Commission
Some travelers may need to pay more to enter parts of Europe come 2026. The price for travel authorization under the European Travel Information and Authorisation System is set to nearly triple, according to an announcement from the European Commission Friday. The system, known as ETIAS, hasn't been implemented yet. The authorization, which was adopted in 2018, has been postponed several times, and is now set to take effect in the fourth quarter of 2026. A proposal was made to increase the fee from 7 euros ($8) to 20 euros ($23), according to the announcement. Inflation and additional operational costs were reasons for the price hike, according to the announcement. The new fee comports with the price of other travel authorizations, such as the U.K.'s Electronic Travel Authorisation (ETA) and the U.S.' Electronic System for Travel Authorization, known as ESTA, the European Commission said. Currently, an ETA costs £16 ($21.70), and the ESTA costs $21. The ETIAS travel authorization applies to visa-exempt travelers who want to visit 30 European countries for stays of up to 90 days in a 180-day period. Some travelers are exempt from the fee, including those who are under 18 years old or over 70 years old, as well as family members of European Union citizens. Travelers from 59 places will need to obtain an ETIAS authorization, including those from Australia, Canada, Japan, Singapore, South Korea, the United States and the United Kingdom. The proposed adjustment is subject to a two-month review period by the European Council and Parliament, according to the announcement.
Washington Post
a minute ago
- Washington Post
Protests flare in Ukraine after government curbs corruption watchdogs
KYIV — Mass protests erupted in Kyiv and other Ukrainian cities late Tuesday after the country's parliament passed legislation many fear will neutralize the country's main anti-corruption bodies and roll back reforms introduced after a pro-Western revolution 10 years ago. The government move against the anti-corruption bodies has alarmed former officials, concerned Ukraine's European allies and thrown back into the spotlight an issue long used by the country's detractors to criticize it. It could also affect Ukraine's application to join the European Union.
Forbes
a minute ago
- Forbes
Trump's Risk With Looming European Union Trade War: Maybe Your Health
President Trump met with Ireland's prime minister, or taoiseach, Micheal Martin, at the White House ... More in March, a few week before Liberation Day on April 2, when Trump announced his global trade war, and well before threatening 30% tariffs on the 27-nation European Union, set to go into effect on Aug. 1. Ireland is a large supplier of critical, often life-saving medicines to the United States. The European Union dominates a wide range of U.S. imports of medicines for treating diabetes, high blood pressure, depression and cancers as well as many of the chemical compounds that are then used to produce some of these same drugs and others domestically. That's why, with President Trump's threatened 30% tariffs on the 27-nation European Union set to go into effect on Aug. 1, the stakes are more consequential to Americans than with trade wars he initiated with countries that provide cell phones, sweaters, toys or even motor vehicle parts. Increased costs for critical medicines would hit the nation's poorest and uninsured the hardest, of course. The European Union is sending some signals that it does not intend to back down. The tariff fight with the European Union is unique in that Trump tends to prefer bilateral negotiations; the European Union is composed of 27 countries. Trump has twice delayed imposing most of the tariffs he initially announced on April 2 against the world, including more than 100 nations with which the United States has a trade surplus. The 10% baseline tariffs are in effect as well as some other industry-specific tariffs. In taking on China, Canada, Mexico and the European Union, Trump is focusing on some of the largest U.S. trade deficits – but at the same time focusing on some of the United States' largest export markets, damaging a key metric in the process. Overall, the European Union is accounting for 20.22% of all U.S. imports and 18.57% of all U.S. exports through May, the latest data available from the U.S. Census Bureau. To see what imports would be most detrimental to the United States should the 30% tariffs actually go into effect next Friday, I focused on the categories of imports where the European Union has the greatest market share globally. I focused on the top 50, which account for 73.29% of all its imports through May rather than all 1,200-plus. (For those familiar with the harmonized system, I am working at the four-digit level.) What I found was that six of the 10 with the largest global market share were related to healthcare, ranging from 62.36% for one to 99.22% to another. While medicines that are critical to Americans' health, and sometimes their lives, are in the bull's eye of American health, so too are U.S. exports for Europeans' health and well-being. Six of the top 10 U.S. exports, calculated as in the manner described for imports above, are also related to healthcare. In fact, three of the six are the same for both exports and imports. On the export list, the European Union percentage of these six U.S. exports ranges from 46.78% to 98.86%. Ireland dominates U.S. imports from the world of the category that includes insulin, hormones and ... More steroids. Looking first at the U.S. imports, 99.22% of $42.95 billion in U.S. shipments in the insulin, hormone and steroid category (HS code 2937) are from the European Union, with 98.48% coming from Ireland. It is the top import from the European Union this year. The same category is a top U.S. export to the European Union, accounting for 53.85% of $4.94 billion in U.S. exports to the world, ranking fourth overall. The category that includes U.S. imports of plasma, vaccines and other blood "fractions" experienced ... More its best May ever. topping $10 billion for the first time. In the import category of plasma, vaccines and other blood 'fractions,' 84.56% of the $54.29 billion total is entering from the European Union. Ireland and Germany are accounting for 47.57% of all U.S. imports in this category (HS code 3002) while the Netherlands, Belgium, France, Switzerland and Italy account for another 28.07%. It is the second most important import from the European Union this year. On the export side, the United States sends 53.85% of the $22.97 billion in shipments to the world to the European Union. It is the United States' fourth-ranked export to the European Union. The third category (HS code 3003) that appears on both top 10 lists is for pharmaceuticals that are not in an individual dose form, such as pills. On the U.S. import side, the European Union accounts for 76.05% of the $1.33 billion total through May; on the U.S. export side, the European Union accounts for 85.03% of the $541.75 million total. On the import side, there are two categories of heterocyclic compounds, commonly used in the production of medicines. With one (HS code 2934), the European Union accounts for 84.56% of all U.S. imports and the other (HS code 2935), 62.36%. The value of the first is $4.48 billion, with the second at $2.61 billion. The sixth and final import category where the European Union has the greatest market share is a category which, is something of a grab bag of chemical contraceptives, contrast agents administered during X-rays and other tests, and so-called sterile surgical catgut, which is used for internal stitches. In the case of the European Union, 74.37% of the $2.42 billion global total, $1.1 billion is chemical contraceptives. Two of the four categories among the top 10 on the import side that do not fall under the broad umbrella of the healthcare industry are, however, well known U.S. imports from Europe, wine and perfume. The European Union is responsible for 79.77% of the $2.97 billion in wine imports into the United States through May and 80.78% of $2.15 billion in perfumes. While these are the U.S. import categories that the European Union dominates by global market share, they are not the largest by value. Among those not mentioned above for market share that are among the top 10 by value from the European Union: Switching over to the U.S. export side, these three were among those with the largest market share not previously mentioned: Four top 10 exports by value, rather than market share, headed to the European Union are worth mentioning: The range of U.S. imports sent from the European Union and U.S. exports to the European Union is wide-ranging but when looking just as where the E.U. is either a dominant importer into the United States or buyer of U.S. exports, healthcare holds a dominant presence, making Trump's threatened 30% tariffs on imports from the 27-nation bloc set to go into effect on Aug. 1, particularly risky for Americans and Europeans alike.
